632 results on '"Corry, June"'
Search Results
2. International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma
3. A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials
4. Sexual Health, sexuality and sexual intimacy in patients with head and neck cancer – A narrative review
5. A Longitudinal Study Evaluating Sexual Health Outcomes and Prioritization in Patients Undergoing Chemoradiation for Human Papillomavirus-Associated Oropharyngeal Cancer
6. Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-Pacific
7. Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus–Associated Oropharyngeal Cancer: A TROG 12.01 Secondary Analysis
8. Current management of xerostomia in head and neck cancer patients
9. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement
10. Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
11. Patient- and Clinician-Reported Outcomes in Human Papillomavirus-Associated Tonsillar Carcinoma Treated With Unilateral and Bilateral Intensity Modulated Radiation Therapy–A Substudy From TROG 12.01
12. Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review
13. Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study
14. De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?
15. Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study
16. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
17. Patient-reported quality of life and symptom burden measures in human papillomavirus associated oropharyngeal cancer – A review of the literature and PRO methodology
18. Introducing: The Red Journal Gray Zone
19. Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck Tumours
20. Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial – A Trans-Tasman Radiation Oncology Group study
21. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma
22. Initial surgical management of sporadic medullary thyroid cancer: Guidelines based optimal care ‐ A systematic review
23. Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure
24. Radiation-Induced Sarcomas of the Head and Neck: A Systematic Review
25. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
26. Radiation therapy quality assurance in head and neck radiotherapy – Moving forward
27. Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck Tumours.
28. A Longitudinal Study Evaluating Sexual Health Outcomes and Prioritization in Patients Undergoing Chemoradiation for Human Papillomavirus-Associated Oropharyngeal Cancer
29. Voice Outcomes after Radiotherapy Treatment for Early Glottic Cancer: Long-Term Follow-Up
30. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
31. Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin
32. Outcomes of Routine Intensity Modulated Radiation Therapy Quality Assurance in a Large Head and Neck Cancer Center
33. Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART)
34. Understanding Interactions of Smoking on Prognosis of HPV-Associated Oropharyngeal Cancers
35. Nasal packing does not affect the dosimetry of sinonasal cancers treated with intensity-modulated radiotherapy or volumetric-modulated arc therapy
36. Suppl Figure 4 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma
37. Data from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma
38. Suppl Figure 1 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma
39. Suppl Figure 2 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma
40. Suppl Figure 3 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma
41. Suppl Figure 5 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma
42. Supplementary Figure 3 from Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma
43. Legend for Supplementary Figures 1-5 from Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma
44. Supplementary Figure 4 from Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma
45. Supplementary Figure 2 from Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma
46. Supplementary Figure 1 from Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma
47. Supplementary Figure 5 from Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma
48. Safety and cost analysis of an 18FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation
49. Current Radiotherapy Considerations for Nasopharyngeal Carcinoma
50. Evaluating new treatments for anaplastic thyroid cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.